Table 2. Hematologic and cytogenetic... | American Society of Hematology

Table 2.

Hematologic and cytogenetic responses in nilotinib trials.

Stage of disease	No of patients	CHR, %	MCyR, %	CCyR, %
Abbreviations: CHR, complete hematologic response; CCyR, complete cytogenetic response; MCyR, major cytogenetic response.
Chronic phase¹¹	321	77	57	41
Accelerated phase¹²	136	26	31	19
Blast crisis¹³	136	11	40	29

Stage of disease	No of patients	CHR, %	MCyR, %	CCyR, %
Abbreviations: CHR, complete hematologic response; CCyR, complete cytogenetic response; MCyR, major cytogenetic response.
Chronic phase¹¹	321	77	57	41
Accelerated phase¹²	136	26	31	19
Blast crisis¹³	136	11	40	29